JPWO2021246392A1 - - Google Patents

Info

Publication number
JPWO2021246392A1
JPWO2021246392A1 JP2022528836A JP2022528836A JPWO2021246392A1 JP WO2021246392 A1 JPWO2021246392 A1 JP WO2021246392A1 JP 2022528836 A JP2022528836 A JP 2022528836A JP 2022528836 A JP2022528836 A JP 2022528836A JP WO2021246392 A1 JPWO2021246392 A1 JP WO2021246392A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022528836A
Other languages
Japanese (ja)
Other versions
JP7802665B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021246392A1 publication Critical patent/JPWO2021246392A1/ja
Application granted granted Critical
Publication of JP7802665B2 publication Critical patent/JP7802665B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/06—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/24—Lactobacillus brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2022528836A 2020-06-02 2021-06-01 乳酸菌増殖促進剤 Active JP7802665B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020096288 2020-06-02
JP2020096288 2020-06-02
PCT/JP2021/020796 WO2021246392A1 (ja) 2020-06-02 2021-06-01 乳酸菌増殖促進剤

Publications (2)

Publication Number Publication Date
JPWO2021246392A1 true JPWO2021246392A1 (https=) 2021-12-09
JP7802665B2 JP7802665B2 (ja) 2026-01-20

Family

ID=78831110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022528836A Active JP7802665B2 (ja) 2020-06-02 2021-06-01 乳酸菌増殖促進剤

Country Status (7)

Country Link
US (1) US20230151057A1 (https=)
EP (1) EP4159742A4 (https=)
JP (1) JP7802665B2 (https=)
CN (1) CN115551991A (https=)
AU (1) AU2021282621A1 (https=)
TW (1) TW202210628A (https=)
WO (1) WO2021246392A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3928625A4 (en) * 2019-02-19 2022-10-19 Kabushiki Kaisha Yakult Honsha PROCESS FOR THE PRODUCTION OF LACTIC ACID BACTERIA AND/OR BACTERIA OF THE GENUS BIFIDOBACTERIUM
JP2025527593A (ja) * 2022-08-19 2025-08-22 ルブリゾル アドバンスド マテリアルズ， インコーポレイテッド 皮膚、毛髪、爪及び／又は粘膜の処置及び／又はケアに有用な化合物
CN117136963B (zh) * 2023-08-31 2026-01-30 湖南农业大学 一种环二肽在促进植物乳杆菌生长中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010239867A (ja) * 2009-04-01 2010-10-28 Suntory Holdings Ltd 茶殻抽出物を用いた乳酸菌の培養方法
WO2011021524A1 (ja) * 2009-08-19 2011-02-24 国立大学法人名古屋大学 乳酸菌の付着性を誘導するペプチド及びその用途
WO2011027719A1 (ja) * 2009-09-02 2011-03-10 明治乳業株式会社 ラクトバチルス属乳酸菌の増殖促進剤及び／又は生残性向上剤
JP2018139551A (ja) * 2017-02-28 2018-09-13 独立行政法人国立高等専門学校機構 乳酸菌生育促進剤、その製造方法、及びそれを用いた乳酸の製造方法
JP2018530307A (ja) * 2016-09-14 2018-10-18 光明乳業股▲ふん▼有限公司 植物性乳酸菌増殖剤、該増殖剤を添加した発酵製品及び調製方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2254592T3 (da) * 2008-02-28 2019-09-09 Dako Denmark As MHC-multimerer til Borrelia-diagnostik og sygdom
CN101993476B (zh) * 2010-09-10 2013-06-12 华南理工大学 一种酪蛋白活性单肽及其制备方法与应用
CN104711217B (zh) * 2013-12-13 2018-02-27 天津科技大学 一种新型的促进乳酸菌生长的生物活性肽
JP6806686B2 (ja) * 2015-08-27 2021-01-06 アサヒグループホールディングス株式会社 腸内有用菌増殖剤
CN106432419B (zh) * 2016-08-25 2019-02-22 江南大学 一种乳酸片球菌来源的抗菌六肽及其制备方法
JP7065758B2 (ja) 2018-12-13 2022-05-12 株式会社Where ビーコンシステムの設定方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010239867A (ja) * 2009-04-01 2010-10-28 Suntory Holdings Ltd 茶殻抽出物を用いた乳酸菌の培養方法
WO2011021524A1 (ja) * 2009-08-19 2011-02-24 国立大学法人名古屋大学 乳酸菌の付着性を誘導するペプチド及びその用途
WO2011027719A1 (ja) * 2009-09-02 2011-03-10 明治乳業株式会社 ラクトバチルス属乳酸菌の増殖促進剤及び／又は生残性向上剤
JP2018530307A (ja) * 2016-09-14 2018-10-18 光明乳業股▲ふん▼有限公司 植物性乳酸菌増殖剤、該増殖剤を添加した発酵製品及び調製方法
JP2018139551A (ja) * 2017-02-28 2018-09-13 独立行政法人国立高等専門学校機構 乳酸菌生育促進剤、その製造方法、及びそれを用いた乳酸の製造方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAI-LUN, H. ET AL.: "Analysis of novel angiotensin-I-converting enzyme inhibitory peptides from protease-hydrolyzed marin", J. PEPT. SCI., vol. 12, JPN6025020438, 2006, pages 726 - 733, ISSN: 0005682793 *
XIAO, C. ET AL.: "Isolation and identification of alcohol denydrogenase stabilizing peptides from Alcalase digested ch", JOURNAL OF FUNCTIONAL FOODS, vol. 64, no. 103617, JPN6025020437, 2019, ISSN: 0005682794 *

Also Published As

Publication number Publication date
EP4159742A1 (en) 2023-04-05
EP4159742A4 (en) 2024-12-25
US20230151057A1 (en) 2023-05-18
WO2021246392A1 (ja) 2021-12-09
JP7802665B2 (ja) 2026-01-20
AU2021282621A1 (en) 2022-11-10
TW202210628A (zh) 2022-03-16
CN115551991A (zh) 2022-12-30

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
CL2026000307A1 (es) Conjugado de anticuerpo bispecífico-fármaco de camptotecina y uso farmacéutico de este.
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
JPWO2021246392A1 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240502

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250527

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250715

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251015

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251216

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260107

R150 Certificate of patent or registration of utility model

Ref document number: 7802665

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150